Group One Trading’s Applied Therapeutics APLT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-48,675
| Closed | -$4.87K | – | 7581 |
|
|
2025
Q4 | $4.87K | Sell |
48,675
-26,586
| -35% | -$16.9K | ﹤0.01% | 7194 |
|
|
2025
Q3 | $45.5K | Sell |
75,261
-38,464
| -34% | -$18.1K | ﹤0.01% | 6039 |
|
|
2025
Q2 | $35.4K | Sell |
113,725
-32,600
| -22% | -$12.6K | ﹤0.01% | 5846 |
|
|
2025
Q1 | $71.5K | Sell |
146,325
-174,987
| -54% | -$103K | ﹤0.01% | 4874 |
|
|
2024
Q4 | $275K | Buy |
321,312
+161,148
| +101% | +$1.01M | ﹤0.01% | 3668 |
|
|
2024
Q3 | $1.36M | Buy |
+160,164
| New | +$944K | ﹤0.01% | 2044 |
|
|
2024
Q1 | – | Sell |
-16,445
| Closed | -$73.8K | – | 6995 |
|
|
2023
Q4 | $55.1K | Buy |
+16,445
| New | +$40.9K | ﹤0.01% | 4977 |
|
|
2023
Q3 | – | Sell |
-3,501
| Closed | -$5.77K | – | 7609 |
|
|
2023
Q2 | $4.48K | Buy |
3,501
+3,000
| +599% | +$3.98K | ﹤0.01% | 6765 |
|
|
2023
Q1 | $406 | Sell |
501
-585
| -54% | -$576 | ﹤0.01% | 6934 |
|
|
2022
Q4 | $825 | Hold |
1,086
| – | – | ﹤0.01% | 6875 |
|
|
2022
Q3 | $1K | Hold |
1,086
| – | – | ﹤0.01% | 7262 |
|
|
2022
Q2 | $1K | Sell |
1,086
-100
| -8% | -$164 | ﹤0.01% | 7506 |
|
|
2022
Q1 | $3K | Sell |
1,186
-2,343
| -66% | -$6.28K | ﹤0.01% | 7601 |
|
|
2021
Q4 | $32K | Sell |
3,529
-894
| -20% | -$11.7K | ﹤0.01% | 6665 |
|
|
2021
Q3 | $73K | Buy |
4,423
+538
| +14% | +$9.29K | ﹤0.01% | 6217 |
|
|
2021
Q2 | $81K | Buy |
3,885
+3,567
| +1,122% | +$67.5K | ﹤0.01% | 6160 |
|
|
2021
Q1 | $6K | Buy |
+318
| New | +$6.86K | ﹤0.01% | 7188 |
|
Group One Trading's APLT Position: Q1 2026 in Review
Group One Trading sold out of Applied Therapeutics (APLT) in Q1 2026, closing a stake of 48,675 shares — an estimated $4.87K sold.
Group One Trading first reported a position in APLT in Q1 2021 and held it in 17 quarters. The position peaked at $1.36M in Q3 2024. 0 funds tracked by Wall St. Rank hold APLT as of Q1 2026.
- Group One Trading reported no remaining Applied Therapeutics position as of Q1 2026 after selling out during the quarter.
- Group One Trading sold 48,675 Applied Therapeutics shares in Q1 2026, an estimated $4.87K.
- Group One Trading first reported a position in Applied Therapeutics in Q1 2021 and held it in 17 quarters.
- Group One Trading's Applied Therapeutics position peaked at $1.36M in Q3 2024.
- 0 funds tracked by Wall St. Rank held Applied Therapeutics as of Q1 2026.
Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.